University Health Network
Discovering epigenetic vulnerabilities in poor prognosis
Some leukemia groups are very difficult to treat and the patients have poor survival. We propose to investigate how to inhibit the driving factor in these leukemias by targeting the epigenetic processes that the driver is dependent on. The inhibition will be achieved by drug-like molecules that have a potential to suppress the leukemia cells and be developed for leukemia therapy.